NFKB1 and chronic obstructive pulmonary disease: TRX ameliorates progressive lung destruction in COPD by blocking the pathogenic interactions between oxidative stress and inflammation by inhibiting key inflammation-related transcription factors, such as p38 MAPK and NF-kB, and by directly scavenging oxygen free radicals (Figure 2).